TAIWAN ADVANCED NANOTECH INC. Taiwan Advanced Nanotech Inc. Stock
Equities
6797
TW0006797004
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.4 TWD | +0.33% |
|
+19.22% | -22.05% |
| Sales 2022 | 1.33B 40.97M | Sales 2023 | 246M 7.59M | Capitalization | 1.19B 36.71M |
|---|---|---|---|---|---|
| Net income 2022 | 326M 10.07M | Net income 2023 | -208M -6.42M | EV / Sales 2022 | 0.81 x |
| Net cash position 2022 | 697M 21.52M | Net cash position 2023 | 311M 9.62M | EV / Sales 2023 | 3.57 x |
| P/E ratio 2022 |
5.56
x | P/E ratio 2023 |
-5.71
x | Employees | - |
| Yield 2022 |
5.11% | Yield 2023 |
-
| Free-Float | 75.52% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.33% | ||
| 1 week | +19.22% | ||
| Current month | +13.64% | ||
| 1 month | +13.43% | ||
| 3 months | -4.25% | ||
| 6 months | -24.85% | ||
| Current year | -22.05% |
1 week
24.50
31.10
1 month
24.2031.10
Current year
24.2039.70
1 year
24.2062.40
3 years
24.20225.87
5 years
24.20358.04
10 years
24.20358.04
| Managers | Title | Age | Since |
|---|---|---|---|
Raman Chien
FOU | Founder | - | 04-04-21 |
Zhuo Xing Chen
DFI | Director of Finance/CFO | - | - |
I Ping Lo
DFI | Director of Finance/CFO | - | 20-08-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hsiu Miao Huang
BRD | Director/Board Member | - | 18-06-11 |
Chi I Chang
FOU | Founder | - | 00-04-21 |
Raman Chien
FOU | Founder | - | 04-04-21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-29 | 30.4 | +0.33% | 190,701 |
| 24-05-28 | 30.3 | +6.69% | 418,565 |
| 24-05-27 | 28.4 | +14.52% | 205,538 |
| 24-05-24 | 24.8 | -1.20% | 31,879 |
| 24-05-23 | 25.1 | -1.57% | 31,091 |
End-of-day quote Taipei Exchange, May 28, 2024
More quotes
Taiwan Advanced Nanotech Inc is a Taiwan-based company mainly engaged in provision of automated nucleic acid extraction machines, nanomagnetic bead nucleic acid extraction reagents, automated filling line equipment for DNA/RNA nucleic acid extraction. The main products include SLA series, Maelstrom series and LH series instruments for DNA/RNA nucleic acid extraction; virus nucleic acid extraction reagent 665 series reagents; blood nucleic acid extraction reagent 611/61E series reagents and tissue nucleic acid extraction reagent 6T2/6K2 series reagents. Products are sold to Taiwan, South Korea, China and other countries.
| 1st Jan change | Capi. | |
|---|---|---|
| -22.05% | 28.76M | |
| +6.88% | 217B | |
| +10.63% | 190B | |
| +18.16% | 141B | |
| +29.70% | 110B | |
| +1.98% | 64.8B | |
| +14.14% | 52.44B | |
| +3.01% | 49.94B | |
| +4.64% | 42.63B | |
| +1.45% | 35.81B |
- Stock Market
- Equities
- 6797 Stock
